Immunogenicity and Safety Testing of a Group B Intranasal Meningococcal Native Outer Membrane Vesicle Vaccine - Katial, Rohit K.; Brandt, Brenda L.; Moran, Ellen E.; Marks, Stephen; Agnello, Victor; Zollinger, Wendell D. (Infection and Immunity, 2002)
Keywords: Administration, Intranasal; Adult; Antibodies, Bacterial - blood; Antigens, Bacterial - immunology; Bacterial Capsules; Bacterial Outer Membrane Proteins - immunology; Bacteriology; Biological and medical sciences; Consumer Product Safety; Drug Tolerance; Female; Fundamental and applied biological sciences. Psychology; Humans; Immunoglobulin Isotypes - blood; Male; Meningococcal Vaccines - adverse effects; Meningococcal Vaccines - immunology; Microbial Immunity and Vaccines; Microbiology; Middle Aged; Neisseria meningitidis; Neisseria meningitidis - immunology; Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains; Polysaccharides, Bacterial - adverse effects; Polysaccharides, Bacterial - immunology; Vaccination; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies; Vaccines, Synthetic - adverse effects; Vaccines, Synthetic - immunology; United States; North America; America; Human; Nervous system diseases; Immunization; Immune response; Antibody; Enzyme; Toxicity; Neisseriaceae; Neisseria meningitidis; Vaccine; External membrane; Infection; Microorganism capsule; Immunogenicity; Central nervous system disease; Bacteriosis; Bacteria; Micrococcales; Meningitis; Serum; Polysaccharide; Meningococcal disease